Litcius/Paper detail

Optimizing <i>Helicobacter pylori</i> Treatment: An Updated Review of Empirical and Susceptibility Test-Based Treatments

Fumiaki Ishibashi, Sho Suzuki, Mizuki Nagai, Kentaro Mochida, Tetsuo Morishita

2023Gut and Liver31 citationsDOIOpen Access PDF

Abstract

infections. Evidence for the superiority of tailored therapy over empirical therapy is still limited and varies by region and treatment regimen. A network meta-analysis comparing different empirical treatment regimens showed that vonoprazan triple therapy provides a superior eradication effect. Recently, favorable results towards vonoprazan dual therapy have been reported, as it reached eradication levels similar to those of vonoprazan triple therapy. Both vonoprazan dual therapy and tailored therapy based on antibiotic susceptibility tests could contribute to future treatment strategies.

Topics & Concepts

MedicineHelicobacter pyloriRegimenAntimicrobialAntibioticsAntibiotic resistanceIntensive care medicineDrug resistanceCombination therapyPharmacotherapyInternal medicineMicrobiologyBiologyHelicobacter pylori-related gastroenterology studiesVeterinary medicine and infectious diseasesClostridium difficile and Clostridium perfringens research